Sign in
4/A

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-043162

CFO and CBO acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Henderson Molly CFO and CBO 2023-07-14 Grant or award +25,000 95,180 D
Loading xslF345X05/doc4a.xml…